⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 9, 2024The Breast JournalOpen Access

The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset

Nehad M. Ayoub Ghaith M. Al‐Taani Amer E. Alkhalifa Dalia R. Ibrahim Aymen A. Shatnawi

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Breast cancer is a heterogeneous disease. Exploring new prognostic and therapeutic targets in patients with breast cancer is essential. This study investigated the expression of MET, ESR1, and ESR2 genes and their association with clinicopathologic characteristics and clinical outcomes in patients with breast cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ayoub et al. (2024) studied this question.

synapsesocial.com/papers/68e6aebeb6db643587630bc2 https://doi.org/10.1155/2024/2582341

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Genes Co-Expressed with ESR2 Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis2024 · 3 citations
2Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast CancerOriginal Research · 2017 · 1 citations
3The Clinicopathological and Prognostic Significance of the Expression of PD-L1 and MET Genes in Breast Cancer: Potential Therapeutic TargetsPrognostic Study · 2024
4The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast CancerPrognostic Study · 2016 · 19 citations
5High MET expression is an adverse prognostic factor in patients with triple-negative breast cancerPrognostic Study · 2013 · 102 citations
6Expression and Prognostic Potential of ESR1 in Breast Cancer2024
7Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumorsPrognostic Study · 2022 · 72 citations
8Clinical insights into the genomic landscape of ESR1-mutated breast cancer and implications for treatment decision-making: a large-scale analysis of 6,162 patientsOriginal Research · 2026
9Clinical Characteristics and Prognostic Risk Factors in Breast Cancer With Liver MetastasisThe Breast Journal · 2026
10Effectiveness and Safety of Hypofractionated Radiotherapy in Patients With Ductal Carcinoma In Situ (DCIS)The Breast Journal · 2026

More from The Breast Journal

More from Medical University of South Carolina

More from Jordan University of Science and Technology

More from Yarmouk University